Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 68 | 78 | +10 |
| Shares | 13.4M | 13.6M | +209.8K (+1.6%) |
| Value | $81.6M | $112.9M | +$31.3M (+38.4%) |
New holders (16)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 78,661 | $652.9K | 0.10% |
| Citadel Advisors LLC | 46,783 | $388.3K | 0.00% |
| Manatuck Hill Partners, LLC | 30,200 | $250.7K | 0.09% |
| Arrowstreet Capital, Limited Partnership | 27,055 | $224.6K | 0.00% |
| Bridgeway Capital Management, LLC | 24,200 | $200.9K | 0.00% |
| Deutsche Bank AG | 22,328 | $185.3K | 0.00% |
| Tang Capital Management LLC | 20,527 | $170.4K | 0.01% |
| Millennium Management LLC | 16,334 | $135.6K | 0.00% |
| HighTower Advisors, LLC | 15,000 | $124.5K | 0.00% |
| HRT Financial LP | 12,395 | $102.0K | 0.00% |
| Invesco Ltd. | 11,360 | $94.3K | 0.00% |
| Price T Rowe Associates Inc | 11,220 | $94.0K | 0.00% |
| Federated Hermes, Inc. | 789 | $6.55K | 0.00% |
| Fifth Third Bancorp | 158 | $1.31K | 0.00% |
| Essential Partners LLC | 24 | $199 | 0.00% |
| TD Waterhouse Canada Inc. | 18 | $149 | 0.00% |
Sold out (6)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| DG Capital Management, LLC | 84,213 | $512.9K |
| Wexford Capital LP | 26,414 | $160.9K |
| Pinnacle Wealth Planning Services, Inc. | 15,419 | $93.9K |
| Corebridge Financial, Inc. | 11,664 | $71.0K |
| Coldstream Capital Management Inc | 625 | $3.81K |
| IFP Advisors, Inc | 7 | $43 |